Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (417)	11/15/1998 11:27:00 AM
From: Dennis	Read Replies (1) \| Respond to of 645

Hey TD, how are you all doin ......heard you had a lot of rain again. Bummer. Hope everything is OK with you all. I think avir is holding up incredibly well considering the missed estimates on Nov. 10.....I may buy some more this week......still sitting on 400 at 28......great timing on my part. gg Good Luck

To: Arthur Radley who wrote (417)	11/25/1998 3:01:00 PM
From: Henry Niman	Read Replies (1) \| Respond to of 645

CNBC caller just asked about Biopharmaceuticals on the Taking Stock segment. Guest initially comment on the "Biopharmaceutical" term, noting that some of the larger Biotechs were actually making a profit, but she thought that small caps were getting a bit more attention and more could be made there. When pressed for a name, she mentioned AVIR, noting the potential market for a nasal flu vaccine in children. She then added that they liked LGND also.